Aims: Involuntary Detrusor Contraction (IDC) may alter therapeutic plans; therefore, urodynamic demonstration (UD) is pivotal. We explore if same session repetitions enhance its demonstration and minimize false-negative results. Methods: Two hundred fifty two women (mean age 47 ± 5.7) had 4 full repetitions of UD with the last round filled with 4°C fluid (Ice-water test). IDC was diagnosed if with at least 3 cm H2O after artifacts were ruled out. Results: 44.4% of the cases showed IDC in the first round of the exam but it could be demonstrated in 88.5% of the women if 4 rounds are taken into account. Only 2 cases showed IDC exclusively in the first round. Nine cases (3.5%) showed IDC in the first round and only on Ice-test, while all other IDC-detected cases revealed it in scattered patterns along the repetitions. Likewise, IDC detection on the second, third and fourth rounds varied widely and unpredictably, many failing to show a consistent pattern of presentation after its detection. IDC wave amplitude did not show any correlation to the detection. Conclusions: Urodynamic repetition is a necessary procedure where IDC is important to demonstrate, as its false-negative rate is high and its unpredictable pattern of detection may be improved by repetition.

Keywords:
Incontinence, Urodynamics, Detrusor, Bladder, Voiding dysfunctions
1.
Schafer W, Abrams P, Liao L, et al: Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 2002;21:261-274.
2.
Rodrigues P, Hering F, Dias EC: Female obstruction after incontinence surgery may present different urodynamic patterns. Int Urogynecol J 2013;24:331-336.
3.
Kulseng-Hanssen S, Husby H, Schiotz HA: Follow-up of TVT operations in 1,113 women with mixed urinary incontinence at 7 and 38 months. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:391-396.
4.
Schrepferman CG, Griebling TL, Nygaard IE, et al: Resolution of urge symptoms following sling cystourethropexy. J Urol 2000;164:1628-1631.
5.
Hsiao SM, Chang TC, Lin HH: Risk factors affecting cure after mid-urethral tape procedure for female urodynamic stress incontinence: comparison of retropubic and transobturator routes. Urology 2009;73:981-986.
6.
Digesu GA, Hutchings A, Salvatore S, Selvaggi L, Khullar V: Reproducibility and reliability of pressure flow parameters in women. BJOG 2003;110:774-776.
7.
Andersen JR, Lose G, Norgaard M, et al: Terodiline, emepronium bromide or placebo for treatment of female detrusor overactivity? A randomised, double-blind, cross-over study. Br J Urol 1988;61:310-313.
8.
Bellucci CH, Wöllner J, Gregorini F, Birnböck D, Kozomara M, Mehnert U, Kessler TM: Neurogenic lower urinary tract dysfunction - do we need same session repeat urodynamic investigations? J Urol 2012;187:1318-1323.
9.
Homma Y, Kondo Y, Takahashi S, Kitamura T, Kawabe K: Reproducibility of cystometry in overactive detrusor. Eur Urol 2000;38:681-685.
10.
Al-Hayek S, Belal M, Abrams P: Does the patient's position influence the detection of detrusor overactivity? Neurourol Urodyn 2008;27:279-286.
11.
Broekhuis SR, Kluivers KB, Hendriks JC, et al: Reproducibility of same session repeated cystometry and pressure-flow studies in women with symptoms of urinary incontinence. Neurourol Urodyn 2011;30:1356-1360.
12.
Rodrigues P, Hering F, Campagnari JC: Involuntary detrusor contraction is a frequent finding in patients with recurrent urinary tract infections. Urol Int 2014;93:67-73.
13.
Rahmanou P, Chaliha C, Kulinskaya E, Khullar V: Reliability testing of urodynamics, pressure flow studies and cough leak point pressure in women with urodynamic stress incontinence with and without detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:933-938.
14.
Whiteside JL, Hijaz A, Imrey PB, Barber MD, Paraiso MF, Rackley RR, Vasavada SP, Walters MD, Daneshgari F: Reliability and agreement of urodynamics interpretations in a female pelvic medicine center. Obstet Gynecol 2006;108:315-323.
15.
Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-160.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.